News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|June 19, 2012

Impetigo on the Face of an Infant

Read here for more details...

Photo courtesy of Ted Rosen, MD

What’s your diagnosis?

Please leave your comments below and click here for answer and discussion.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Vosoritide data support planned FDA submission for hypochondroplasia | Image Credit: © Scott Cornell- stock.adobe.com.

Vosoritide data support planned FDA submission for hypochondroplasia

ByMorgan Ebert, Executive Editor

June 16th 2026

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency

ByMorgan Ebert, Executive Editor

June 16th 2026

Diazoxide choline data show durable hyperphagia gains in Prader-Willi syndrome | Image Credit: © Yurii Kibalnik - stock.adobe.com.

Diazoxide choline data show durable hyperphagia gains in Prader-Willi syndrome

ByMorgan Ebert, Executive Editor

June 16th 2026

Setmelanotide shows interim phase 2 signals in Prader-Willi syndrome | Image Credit: © Yurii Kibalnik - stock.adobe.com

Setmelanotide shows interim phase 2 signals in Prader-Willi syndrome

ByMorgan Ebert, Executive Editor

June 16th 2026

Acoustic resonance therapy shows promise for pediatric chronic rhinitis

Acoustic resonance therapy shows promise for pediatric chronic rhinitis

ByMorgan Ebert, Executive Editor,Paramesh Gopi, PhD

June 16th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Vosoritide data support planned FDA submission for hypochondroplasia

Diazoxide choline data show durable hyperphagia gains in Prader-Willi syndrome

Setmelanotide shows interim phase 2 signals in Prader-Willi syndrome

pCPA receives FDA Orphan Drug Designation for monoamine oxidase deficiency